Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease

Wei-Bin Shen1, Montasir Elahi1, Bingbing Wang1

  • 1Department of Obstetrics, Gynecology & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

Abstract

Insights

Apoptosis signal-regulating kinase 1 (ASK1) activation and insulin receptor (IR) signaling impairment precede Alzheimer's disease (AD) onset. These pathways are persistently altered in AD pathogenesis, suggesting a link between oxidative stress and insulin resistance.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cellular Signaling

Background:

  • Alzheimer's disease (AD) pathogenesis involves complex signal transduction pathways.
  • Apoptosis signal-regulating kinase 1 (ASK1) and insulin receptor (IR) signaling are implicated in AD development.

Purpose of the Study:

  • To investigate the temporal relationship between ASK1 activation, IR signaling impairment, and AD.
  • To determine if these molecular alterations precede or coincide with overt AD symptoms.

Main Methods:

  • Utilized immunostaining, immunoblotting, and quantitative PCR on postmortem brain tissues and AD patient-derived iPSCs.
  • Assessed levels of ASK1 and IR signaling intermediates, including phosphorylated proteins and glucose transporter 3 (GLUT3).
  • Examined young AD transgenic mice before and during neuropathology onset.

Main Results:

  • ASK1 signaling was activated in APOE4 carriers and AD brains, evidenced by increased p-ASK1 and reduced TRX1.
  • Impaired IR signaling was observed, with increased IRS1 phosphorylation and decreased p-AKT1, p-IRβ, and GLUT3 expression.
  • These molecular changes, including GLUT3 reduction, were detected in AD models prior to overt neuropathology and clinical symptoms.

Conclusions:

  • Oxidative stress-responsive kinase activation and reduced IR signaling are early and persistent events in AD pathogenesis.
  • Evidence suggests a potential crosstalk between ASK1 signaling and insulin resistance in the etiology of AD.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
635
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
158
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
58
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
248
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.7K